کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3283040 | 1209166 | 2011 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
ElectrogastrographyFDAGLPGastroparesis5-HT4GCSInNOSGES5-hydroxytryptamineVIPICCIGFiPS - IPSneuronal nitric oxide - اکسید نیتریک عصبیDiabetes - بیماری قندgastric electrical stimulation - تحریک الکتریکی معدهEgg - تخممرغPharmacotherapy - داروسازیTreatment - درمانFood and Drug Administration - سازمان غذا و داروinterstitial cells of Cajal - سلولهای بینابینی CajalGastroparesis Cardinal Symptom Index - شاخص علائم گاستاپراسس کاردینالconfidence interval - فاصله اطمینانInsulin-like growth factor - فاکتور رشد مانند انسولینVasoactive intestinal polypeptide - پلیپپتید روده روغنیglucagon-like peptide - پپتید مشابه گلوکاگون
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
بیماریهای گوارشی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis](/preview/png/3283040.png)
چکیده انگلیسی
Recent evidence of the significant impact of gastroparesis on morbidity and mortality mandates optimized management of this condition. Gastroparesis affects nutritional state, and in diabetics it has deleterious effects on glycemic control and secondary effects on organs that increase mortality. First-line treatments include restoration of nutrition and medications (prokinetic and antiemetic). We review the epidemiology, pathophysiology, impact, natural history, time trends, and treatment of gastroparesis, focusing on diabetic gastroparesis. We discuss pros and cons of current treatment options, including metoclopramide. Second-line therapeutic approaches include surgery, venting gastrostomy or jejunostomy, and gastric electrical stimulation; most of these were developed based on results from open-label trials. New therapeutic strategies for gastroparesis include drugs that target the underlying defects, prokinetic agents such as 5-hydroxytryptamine agonists that do not appear to have cardiac or vascular effects, ghrelin agonists, approaches to pace the stomach, and stem cell therapies.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Gastroenterology and Hepatology - Volume 9, Issue 1, January 2011, Pages 5-12
Journal: Clinical Gastroenterology and Hepatology - Volume 9, Issue 1, January 2011, Pages 5-12
نویسندگان
Michael Camilleri, Adil E. Bharucha, Gianrico Farrugia,